الانتقال إلى المحتوى الرئيسي
xMedica

NCT07321899ClinicalTrials.gov

Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation

Transcatheter Tricuspid Valve Replacement Using the Medtronic Intrepid™ TTVR System in Patients With Severe Symptomatic Tricuspid Regurgitation - PATHFINDER

قيد التجنيديقبل مشاركين الآن، وفقاً لسجل السجل.
التواصل مع هذه الدراسة

باختصار

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

تدخّليةمطلوب 1,186 مشاركاً20 موقعاًدولة واحدة

الفئات

مسجَّلة في سجل واحد

يمكن أن تُسجَّل دراسة واحدة في عدة سجلات. نعرضها مرة واحدة ونربط بكل سجل نحتفظ به.

تُعرض معلومات التجربة كما نشرها السجل، بلغتها الأصلية.

هل أنت مهتم بهذه الدراسة؟

تسجيل الدخول أو أنشئ حسابًا لتسجيل اهتمامك ومتابعة هذه الدراسة.

How this study is set up

The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.

  • Present: Registered before enrolment beganFirst posted 2026-01-07; recorded start 2026-09-11
  • Present: Has a defined primary outcomeA primary outcome measure is listed in the record
  • Present: The primary outcome states a time frameThe primary outcome measure records a time frame
  • Present: Participants are randomly assignedAllocation is recorded as randomised
  • Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
  • Present: Uses blinding (masking)A masking level is recorded in the record
  • Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
  • Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
  • Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
  • Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
  • Present: Sponsor has 19 other studies in this databaseCounted from the lead sponsor named in the record (Medtronic Cardiovascular)
  • Present: Sponsor has posted results for at least one studyBased on the sponsor’s studies in this database
  • The record lists 1 condition.
  • Lead sponsor type recorded as: industry.

Trial stature

Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.

Methodological rigourSTRONG

A strong methodological design for a study of this type, judged from its ClinicalTrials.gov record.

How this score is built
  • Randomised allocation20/20

    Participants are randomly allocated between arms

  • Blinding7/20

    Single-blind

  • Control arm15/15

    Active-comparator control arm

  • Primary-outcome specificity10/10

    Named primary outcome with a defined time frame

  • Endpoint type3/10

    Surrogate or intermediate endpoint (conservative default)

  • Multi-centre5/8

    Multi-centre: 4 sites

  • Data monitoring committee7/7

    A data monitoring committee is in place

  • Prospective registration5/5

    Registered before the study start date

  • Protocol / SAP posted0/5

    No protocol or SAP posted to the registry

ScaleLARGE

A large study: 1,186 participants (target), run at 20 sites.

How this score is built
  • Enrolment31/40

    1,186 participants (target)

  • Site count7/25

    4 sites

  • Country count0/15

    Single country

  • Planned duration10/10

    Planned over about 179 months

  • Sponsor scale4/10

    Medtronic Cardiovascular has led 19 trials in our corpus

Investigator standingUNKNOWN

We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.

How this score is built
  • Investigator standing0/100

    No investigator recorded in the registry for this trial

These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.

ملخص

This clinical trial evaluates the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in symptomatic patients with severe or greater tricuspid regurgitation.

Prospective, global, pre-market, interventional, multi-center, randomized controlled pivotal trial to evaluate the safety and effectiveness of the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System compared to Edwards EVOQUE TTVR System in symptomatic patients with severe or greater tricuspid regurgitation.

الحالات

  • Severe Tricuspid Regurgitation

الأهلية

الأهلية
الجنسالجميع
الأعمار18 Years – لا حد أقصى
المتطوعون الأصحّاءلا

الأهلية كما كُتبت في السجل

Inclusion Criteria: * Age ≥18 years at the time of consent. * Severe symptomatic tricuspid regurgitation (TR) despite optimal medical therapy (OMT). * Local site multidisciplinary heart team experienced in tricuspid valve therapies agrees that the subject is appropriate for TTVR. Exclusion Criteria: * Any tricuspid device currently in place. * Anatomic contraindications. * Need for emergent or urgent surgery. * Left ventricular ejection fraction \<25%.

الأهلية في عبارات بسيطة

لم تُقسَّم معايير هذا السجل إلى عبارات منفصلة بعد. نص السجل أعلاه كامل وهو النسخة المُعتمَدة.

تصميم الدراسة

تصميم الدراسة
نوع الدراسةتدخّلية
المرحلةغير منطبق
التخصيصمعشّاة
نموذج التدخّلPARALLEL
الغرض الأساسيTREATMENT
التعميةSINGLE (1)
التجنيدمطلوب 1,186 مشاركاً

الجهة الراعية والمتعاونون

  • Medtronic Cardiovascular الجهة الراعية

الأذرع والتدخلات

  • Medtronic Intrepid™ TTVREXPERIMENTAL

    Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation.

  • Edwards EVOQUE TTVRACTIVE_COMPARATOR

    Transcatheter tricuspid valve replacement with Edwards EVOQUE TTVR in patients with severe or greater tricuspid regurgitation.

  • Single Arm RegistryEXPERIMENTAL

    Transcatheter tricuspid valve replacement with Medtronic Intrepid™ TTVR System in patients with severe or greater tricuspid regurgitation who are not eligible for randomization.

التدخلات

  • جهاز Edwards EVOQUE Tricuspid Valve Replacement (TTVR) System

    Transcatheter Tricuspid Valve Replacement

  • جهاز Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System

    Transcatheter Tricuspid Valve Replacement

مقاييس النتائج

  1. مقياس النتيجة الأولي

    Rate of Major Adverse Events (MAE)

    الإطار الزمني 30-days post-procedure

  2. مقياس النتيجة الأولي

    Composite Endpoint: All-cause mortality, Heart failure hospitalization, and tricuspid valve reintervention

    الإطار الزمني 1-year post-procedure

  3. مقياس النتيجة الثانوي

    Tricuspid regurgitation (TR) grade reduction

    Total number of patients with at least one grade TR reduction

    الإطار الزمني 6 months post-procedure

  4. مقياس النتيجة الثانوي

    Change in quality of life (QoL) as measured by the Kansas City Cardiomyopathy Questionnaire (KCCQ) from baseline

    KCCQ overall summary score is a patient-reported measure of health status. Scores range from 0 to 100 where higher scores reflect better quality of life

    الإطار الزمني 6 months post-procedure

  5. مقياس النتيجة الثانوي

    All-cause mortality

    الإطار الزمني 12 months post-procedure

  6. مقياس النتيجة الثانوي

    Heart failure hospitalization

    الإطار الزمني 12 months post-procedure

  7. مقياس النتيجة الثانوي

    New onset conduction disturbance (NOCD)

    الإطار الزمني 30 days post-procedure

  8. مقياس النتيجة الثانوي

    Total procedure time

    الإطار الزمني Procedure

  9. مقياس النتيجة الثانوي

    Right ventricle (RV) dysfunction

    الإطار الزمني 12 months post-procedure

التواريخ

التواريخ
تاريخ البدء11 سبتمبر 2026 (فعلي)
الإتمام الأولي1 سبتمبر 2031 (تقديري)
الإتمام1 أبريل 2041 (تقديري)
أول نشر7 يناير 2026 (فعلي)
آخر تحديث12 نوفمبر 2026
النتائج منشورةغير مذكور في سجل السجل
آخر تأكيد للحالةنوفمبر 2026

فعلي يعني أن الحدث وقع. تقديري يعني أن الجهة الراعية تتوقعه. للكلمتين معنيان مختلفان.

المواقع

20 موقعاً قيد التجنيد

United States

United States
المنشأةالمدينةالولاية أو المنطقةالحالة
Emory University Hospital MidtownAtlantaGeorgiaقيد التجنيد
University of Alabama at Birmingham (UAB) HospitalBirminghamAlabamaقيد التجنيد
Buffalo General Medical CenterBuffaloNew Yorkقيد التجنيد
Northwestern Memorial HospitalChicagoIllinoisقيد التجنيد
The Christ HospitalCincinnatiOhioقيد التجنيد
Cleveland Clinic FoundationClevelandOhioقيد التجنيد
Hartford HospitalHartfordConnecticutقيد التجنيد
Cedars Sinai Medical CenterLos AngelesCaliforniaقيد التجنيد
Northwell Health North Shore University HospitalManhassetNew Yorkقيد التجنيد
Abbott Northwestern HospitalMinneapolisMinnesotaقيد التجنيد
Morristown Medical CenterMorristownNew Jerseyقيد التجنيد
Yale New Haven HospitalNew HavenConnecticutقيد التجنيد
Montefiore Medical CenterNew YorkNew Yorkقيد التجنيد
NYU Langone Medical CenterNew YorkNew Yorkقيد التجنيد
The Valley HospitalParamusNew Jerseyقيد التجنيد
Abrazo Arizona Heart HospitalPhoenixArizonaقيد التجنيد
Kaiser Permanente San Francisco Medical CenterSan FranciscoCaliforniaقيد التجنيد
Los Robles Hospital & Medical CenterThousand OaksCaliforniaقيد التجنيد
Ascension Via Christi Saint FrancisWichitaKansasقيد التجنيد
Lankenau Institute for Medical ResearchWynnewoodPennsylvaniaقيد التجنيد

مستندات الدراسة

لا تُرتبط أي مستندات في سجل السجل هذا.

التغيّرات عبر الزمن

  1. 12 نوفمبر 2026

    أُضيف موقع

    7 sites added (20 total)

    1320

  2. 25 سبتمبر 2026

    أُضيف موقع

    9 sites added (13 total)

    413

  3. 28 يوليو 2026

    تغيّرت الحالة

    Status changed from Not yet recruiting to Recruiting

    NOT_YET_RECRUITINGRECRUITING

  4. 28 يوليو 2026

    فُتح التجنيد

    Recruitment opened

    NOT_YET_RECRUITINGRECRUITING

  5. 28 يوليو 2026

    أُضيف موقع

    4 sites added (4 total)

    04